In Brief Neukomm and Burdett et al. identify the novel BTB/BACK domain molecule Axundead as required for axotomyinduced axon degeneration in Drosophila. axundead mutants provide long-term functional preservation of severed axons and block neurodegeneration induced by genetic activation of axon death signaling or blockade of NAD + biosynthesis.
SUMMARY
Axon degeneration is a hallmark of neurodegenerative disease and neural injury. Axotomy activates an intrinsic pro-degenerative axon death signaling cascade involving loss of the NAD + biosynthetic enzyme Nmnat/Nmnat2 in axons, activation of dSarm/Sarm1, and subsequent Sarm-dependent depletion of NAD + . Here we identify Axundead (Axed) as a mediator of axon death. axed mutants suppress axon death in several types of axons for the lifespan of the fly and block the pro-degenerative effects of activated dSarm in vivo. Neurodegeneration induced by loss of the sole fly Nmnat ortholog is also fully blocked by axed, but not dsarm, mutants. Thus, pro-degenerative pathways activated by dSarm signaling or Nmnat elimination ultimately converge on Axed. Remarkably, severed axons morphologically preserved by axon death pathway mutations remain integrated in circuits and able to elicit complex behaviors after stimulation, indicating that blockade of axon death signaling results in long-term functional preservation of axons.
INTRODUCTION
Maintenance of the morphological integrity of neurons is essential for sustained nervous system function throughout an animal's lifespan. Nervous system injury or neurological disease leads to axonal and synaptic degeneration and, in turn, loss of neural circuit connectivity and function (Conforti et al., 2014) . Molecular pathways driving axonal degeneration remain poorly defined in any context; however, recent work on Wallerian degeneration (WD) has revealed that axon injury activates an intrinsic, conserved, pro-degenerative (axon death) signaling pathway. We previously identified dSarm/Sarm1 (sterile a/Armadillo/Toll-Interleukin receptor homology domain protein) as a key mediator of axon death signaling (Osterloh et al., 2012) . Loss of dSarm in Drosophila, or Sarm1 in mouse, resulted in severed distal axons remaining morphologically preserved for weeks after injury (Gerdts et al., 2013; Osterloh et al., 2012) , indicating that dSarm/Sarm1 pro-degenerative signaling is an ancient mechanism used by axons to drive self-destruction. How dSarm/Sarm1 signals to execute axon death remains unclear, but dSarm/Sarm1 has recently been linked to the NAD + metabolic pathway (Essuman et al., 2017; Gerdts et al., 2015; Sasaki et al., 2016) , which based on extensive evidence appears to be a central mediator of axonal integrity.
The first evidence supporting a role for NAD + in axon maintenance came from the identification and characterization of the slow Wallerian degeneration (Wld S ) mouse, where severed axons fibers survived for weeks when detached from their cell bodies (Lunn et al., 1989) . This remarkable neuroprotective phenotype effect was due to a chromosomal rearrangement that led to the generation of the novel Wld S molecule, a fusion protein consisting of the NAD + biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) and a short fragment of Ube4b (Mack et al., 2001) . Consistent with a positive role for NAD + in sustaining axons, NAD + levels were found to plummet in axons immediately prior to granular fragmentation. Axon degeneration could be rescued by exogenous NAD + or its precursors, and axotomy-induced NAD + depletion was blocked by Wld S (Wang et al., 2005) . Numerous studies have demonstrated neuroprotective roles for NAD + -related metabolites (reviewed in Gerdts et al., 2016) . The current proposed mechanism for activation of axon degeneration after injury is the depletion of Nmnat2, a labile form of Nmnat found in mammalian axons that is normally transported down axons from the soma (Gilley and Coleman, 2010) . Nmnat2 is seen as a critical regulator of axon survival: its halflife approximates the latent phase prior to explosive axon fragmentation, depletion of Nmnat2 from axons induces spontaneous degeneration, and stabilization of Nmnat2 can phenocopy the effects of Wld S (Gilley et al., 2013; Milde et al., 2013a Milde et al., , 2013b ).
The second line of evidence supporting a role for NAD + in axonal protection came from drug screens for molecules that promoted neurogenesis (or neuroprotection) in vivo (Pieper et al., 2010) . P7C3 was identified as an activity-enhancing compound of nicotinamide phosphoribosyltransferase (Nampt), a rate-limiting enzyme in the NAD + salvage pathway, which likely leads to increased levels of NAD + in injured axons to help sustain integrity (Wang et al., 2014) . Derivatives of the P7C3 series have since been shown to be neuroprotective in many models of neurodegenerative disease, and in some models of neural injury (Blaya et al., 2014; De Jesú s-Corté s et al., 2015; Kemp et al., 2015; Tesla et al., 2012; Yin et al., 2014 (Gerdts et al., 2015) . Surprisingly, it appears that the Sarm1 TIR domain harbors endogenous NAD + hydrolase activity (Essuman et al., 2017) . Thus an emerging stepwise model of WD is that axotomy leads to depletion of labile pools of Nmnat2 in axons detached from their cell bodies; this in turn results in an initial depletion of NAD + levels due to lack of new NAD + synthesis and/or salvage, dSarm/Sarm1 signaling is then activated followed by rapid depletion of NAD + levels below a threshold needed to maintain axonal integrity, and finally explosive degeneration of the axon ensues. NAD + depletion from axons is a compelling model for WD, although alternative mechanisms cannot be excluded, due to our limited understanding of the genetics of axon death signaling. Besides dSarm/Sarm1, only one other molecule, the E3 ubiquitin ligase Highwire/Phr1, has been shown to be required for axon death in vivo: loss-of-function mutations in highwire/Phr1 potently suppress axon death in fly nerve injury models and mammalian sciatic nerve lesion experiments (Babetto et al., 2013; Xiong et al., 2012) . Highwire/Phr1 likely acts upstream of dSarm/Sarm1, and is required for the normal turnover of Nmnat/Nmnat2. Loss of Highwire/Phr1 is therefore proposed to stabilize Nmnat/Nmnat2 and maintain axonal pools of NAD + (Babetto et al., 2013) . Are there other signaling molecules acting downstream of dSarm/Sarm1 to execute axonal death, or is NAD + depletion the final step? Sarm1 has also been reported to drive axon death through a downstream MAPK signaling cascade , similar to the signaling mechanism used by C. elegans TIR-1 during regulation of odorant receptor expression (Chuang and Bargmann, 2005) ; however, this remains controversial. A recent contradictory study argues that MAPKs exert their effect by fine-tuning levels of Nmnat2 upstream of Sarm1 signaling (Walker et al., 2017) . In this study, we report the identification and characterization of Axundead (Axed), an axonal BTB and BACK domain protein that signals downstream of dSarm. Axed is essential for injuryinduced axon death signaling, and axed mutations can fully suppress degeneration induced by activated dSarm, or complete elimination of Nmnat activity from axons. Thus, Axed is a novel pro-degenerative signaling molecule, and the neuroprotective effects of loss of Axed exceed those of dsarm null mutants.
RESULTS

Isolation and Characterization of axed Mutants
We sought to identify novel genes required for axon death in vivo. We therefore performed an unbiased F 1 forward genetic screen using mosaic analysis with a repressible cell marker (MARCM) in glutamatergic sensory neurons of the adult Drosophila wing (Lee and Luo, 1999; Neukomm et al., 2014) ( Figure S1 ). Briefly, P 0 males were mutagenized with ethyl methanesulfonate (EMS) and bred to virgin females ( Figure S1A ; detailed genotypes in Table S1 ) to produce F 1 offspring males heterozygous for randomly introduced mutations and homozygous for the same mutations in GFP + -labeled sensory neuron MARCM clones ( Figure S1B ). Sensory neuron axons were severed by surgical removal of the distal half of the wing. Neurons with cell bodies proximal to the cut site served as uninjured controls, while neurons with cell bodies distal to the cut site were axotomized. To quantify axon death, we counted the number of uninjured control axons (cb, indicated in the upper right corner of each figure), and assayed in the most proximal region of the wing vein for additional intact severed axons (severed intact) or uncleared axonal debris ( Figure S1B ). Wild-type axons underwent fragmentation within 12 hr and were cleared from the wing nerve by $5 days post-axotomy (dpa). We assayed for mutants that retained intact, severed GFP + axons 7 dpa (Figure S1B) . In total we screened $10,000 mutagenized arms of chromosome 3L ($20% of the Drosophila genome) and identified three mutants where severed axons remained morphologically intact 7 dpa (3L. 0011, 3L.2094, and 3L.4314, respectively) (Figures S1B and S1C, see below). These F 1 males were crossed to recover mutagenized chromosomes and establish mutant stocks ( Figure S1C ). Prior to injury, axons in each mutant line appeared normal, as did the morphology of sensory neuron cell bodies and dendrites. Uninjured clones survived for up to 50 days (below) and continued to exhibit normal morphology, suggesting that the identified mutations do not have detrimental effects on neuronal survival or morphology. Each of these mutants was homozygous lethal, even after several rounds of outcrossing, suggesting they each affected an essential gene. We therefore performed complementation tests for lethality among these mutants and with the dsarm 896 allele, which is also lethal and on 3L. We defined two complementation groups, one consisting of dsarm 896 and 3L.4314 (hereafter referred to as dsarm 4314 ) and the other one consisting of 3L. 0011 and 3L.2094 (Figure 1A) . Based on the long-term survival of severed axons that should otherwise undergo axon death, we named this complementation group axundead (axed). Axons heterozygous for dsarm 896 or axed 2094 , and axons transheterozygous for , all underwent axon death with kinetics similar to those observed in wild-type axons ( Figure 1B) . We attempted to rescue axon death in axed or dsarm mutants with a bacterial artificial chromosome containing a genomic copy of wild-type dsarm (BAC dsarm Figure 1C ). A total of 100% and 99.3% of severed axed 2094 and axed 0011 mutant axons, respectively, remained intact at 7 dpa ( Figure 1D ). Axon death in cholinergic olfactory receptor neurons (ORNs) is also blocked by axed mutations. While severed wild-type axons degenerated and were cleared within 7 days after axotomy, severed axed mutant axons remained preserved at both 7 and 50 dpa ( Figure 1E ). Thus, the protective effects of axed, like dsarm (Osterloh et al., 2012) and hiw (Neukomm et al., 2014; Xiong et al., 2012) , extend to multiple types of neurons and preserve the morphological integrity of severed axons for the lifespan of the fly. We next wanted to determine whether Axed function is specific for WD: we used the eye-specific glass multimer reporter to ectopically express pro-apoptotic hid (GMR-hid 10 ), which re- sults in widespread cell death in the developing visual system (Bergmann et al., 1998 ) ( Figure S3A ). While mutant clones of the Nedd2-like caspase dronc I29 were able to suppress hid-mediated eye ablation, homozygous axed mutations did not modify cell death in this assay ( Figure S3A ). Likewise, we found that pruning of axons or dendrites in larval mushroom body (MB) g neurons was not affected by axed mutations (Lee et al., 2000) ( Figure S3B ). These observations indicate that loss of Axed, like dSarm (Osterloh et al., 2012) , is sufficient to potently block WD, but not axon degeneration, during developmental pruning or apoptotic cell death.
Axed Encodes a BTB/BACK Domain-Containing Protein We mapped the lethality of axed 0011 and axed 2094 using molecularly defined deficiencies (Dfs) (Figure 2A ) and assayed those Dfs that failed to complement lethality for defects in axon death in homozygous Df MARCM clones ( Figures S4A and S4B ). Both axed alleles failed to complement a large Df ZN47, and within that region one smaller Df, BSC411 (uncovering $100 genes), while all other partially overlapping deficiencies were able complement the lethality of both axed alleles. This allowed us to narrow down the interval to seven candidate genes, of which a single Minos transposon insertion within CG8398 (Mi{MIC} CG8398
MI13270
) failed to complement the lethality of both axed alleles. Consistent with our mapping strategy, MARCM clones of BSC411 or Mi{MIC} 13270 (hereof axed MI13270 ) were also defective in axon death ( Figures S4A and S4B ). We identified a 16 bp deletion in exon 3 in axed 0011 ( Figure S5 ); however, we were not able to identify a molecular lesion within the open reading frame of CG8398 in axed 2094 , suggesting it might be a regulatory mutation (axed alleles listed in STAR Methods). To confirm that CG8398 is axed and required for axon death, we also created de novo axed alleles using two distinct methods, CRISPR/ Cas9 and imprecise transposon excision (Metaxakis et al., 2005; Sebo et al., 2014 , and the deficiency BSC411 (scale bar, 5 mm). Shown are averages (n R 20 wings each).
Minos imprecise excision-based alleles (axed
ExMI07 , axed ExMI65 , and axed
ExMI96
), all failed to complement the lethality of our original axed mutagenesis alleles, and they were also defective in axon death (STAR Methods). We therefore conclude that CG8398 encodes the axed gene and hereafter refer to CG8398 as axed.
The axed locus encodes two predicted isoforms (axed long and axed short , respectively). We generated transgenic flies harboring isoform-specific cDNA rescue constructs containing endogenous 5 0 and 3 0 UTRs under the control of the Gal4/UAS binary expression system (UAS-axed long and UAS-axed short ).
Expression of either construct was sufficient to rescue the axon death phenotype in all axed alleles tested ( Figure 2B ). The predicted Axed protein contains two evolutionary conserved domains, a BTB (bric-à -brac, tramtrack, broad complex) and a BACK (BTB and C-terminal Kelch) domain: BTB mediates protein dimerization, while BTB and BACK together mediate interactions with Cullin ubiquitin ligases (Stogios and Privé , 2004) . The C-terminal domains of BTB and BACK domains often encode the substrate binding domain (Krek, 2003; Pintard et al., 2004; Willems et al., 2004) .
To explore the functional requirements of these domains, we generated deletion constructs lacking either the BTB, the BACK, or the C-terminal domain using axed long as a reference ( Figure 3A ). Each of these constructs, when expressed in S2 cells, generated proteins of the appropriate size, indicating the predicted products are stably expressed in Drosophila cells (Figure 3B) . For in vivo studies, we integrated each construct into the same genomic locus as UAS-axed long and expressed each in wild-type clones as well as axed mutant backgrounds ( Figures  3C and 3D ). Neither expression of full-length Axed nor any of the deletion constructs led to spontaneous degeneration of axons or cell bodies. Moreover, none of these constructs dominantly suppress axon degeneration ( Figure 3D ). In axotomy assays, we found that while full-length axed long rescued axon death to wild-type levels, expression of the construct lacking the BTB domain led to a partial rescue, with $60% axons fragmented or cleared by 7 dpa. Loss of the BACK domain rescued to a lesser extent, with only $25% axons fragmented or cleared by 7 dpa, and the construct lacking the C-terminal domain failed to rescue axon degeneration at any level. While the C-terminal domain appears to be essential for Axed to function in axon death, we cannot exclude the possibility that Axed DCterm could be misfolded or mislocalized. Future studies aimed at identifying Axed binding partners will be essential to define the role of this domain in axon degeneration. Taken together, our data argue that the BTB and BACK domains are functionally important but partially dispensable for Axed function, while the C terminus is likely essential for pro-degenerative Axed signaling during axon death ( Figure 3D ). Many BTB-containing proteins are involved in the recruitment of substrates to Cullin-RING ligase (CRL) complexes for ubiquitin tagging and proteasome degradation (Bennett et al., 2010; Pintard et al., 2003; Xu et al., 2003) . However, none of the CRL complex mutants we assayed resulted in an axon death phenotype (Table S2A ), suggesting that they are not required for axon death or that genetic redundancy among them might mask their roles. , and BSC411, respectively). Empty boxes: normal axon degeneration (100% axon death), boxes with one diagonal line: partial axon death (40%-80% of severed axons remain intact), boxes with two crossing lines: defective axon death (R95% of severed axons remain intact).
Axed Executes dSarm-Mediated Axon Death Signaling
How dSarm/Sarm1 executes axon death remains unclear, although recent studies propose that dSarm/Sarm1 drives axon death by rapid depletion of NAD + (Gerdts et al., 2015) , which has been proposed to be mediated by a novel NAD + hydrolase activity encoded in the Sarm1 TIR domain (Essuman et al., 2017) . We sought to determine where axed functions with respect to dSarm signaling in vivo. dSarm consists of a conserved N-terminal armadillo (ARM), two sterile alpha motifs (2xSAM), and a C-terminal Toll/ interleukin-1 receptor homology (TIR) domain ( Figure S6A ). Consistent with structure and function studies in worms and cultured mouse neurons (Chuang and Bargmann, 2005; Gerdts et al., 2013 Gerdts et al., , 2015 Yang et al., 2015) , we found that all three functional domains were essential to rescue the axon death phenotype in dsarm 896 mutant clones ( Figure S6B ). Expression of constructs lacking the SAM or TIR domains did not dominantly alter axon death in wild-type axons or cause spontaneous axon degeneration in the absence of injury. However, clones expressing dSarm lacking the ARM domain (dsarm DARM ), proposed to be an auto-inhibitory domain in C. elegans (Chuang and Bargmann, 2005) , underwent spontaneous cell body and axon degeneration ( Figure S6B ). To further assess dsarm DARM -induced neurodegeneration in Drosophila, we scored the number of intact axons and cell bodies in age-matched adults at 1-10 days post-eclosion (dpe). We found that dsarm DARM triggered the spontaneous degeneration of axons and cell bodies within 2-3 dpe in wildtype (Figures 4A and 4B) and dsarm mutants lacking endogenous dSarm ( Figure 4C ). dsarm DARM -mediated pro-neurodegenerative phenotypes were also observed in larva when transiently expressing dsarm DARM in ddaC neurons ( Figure S6C ). Activation of dsarm DARM expression in post-mitotic adult PDF + neurons using temperature-sensitive Gal80 ts ON/OFF system to express dsarm DARM drove rapid degeneration of PDF neurons (Figure S6D) . Thus, activation of dsarm DARM in post-mitotic neurons is sufficient to drive their rapid degeneration even in the absence of injury in vivo. Co-expression of P35, a broad apoptosis inhibitor, did not alter dsarm DARM -induced neurodegeneration in any cell type. In contrast, co-expression of Wld S , a potent inhibitor of WD, was able to partially suppress cell body and axon degeneration induced by dsarm DARM ( Figures 4C, S6C , and S6D). Thus, dsarm DARM is a gain-of-function allele of dSarm that is sufficient to activate Wallerian-like degeneration in vivo. Similar effects have been described using genetically engineered versions of the TIR domain that are activated by chemical dimerization (Gerdts et al., 2015; Yang et al., 2015) . Therefore, dSarm DARM activates a Wallerian-like program of degeneration in vivo, and Wld s activity is sufficient to partially overcome pro-degenerative dSarm signaling. The C. elegans dSarm/Sarm1 homolog tir-1 has been shown to act upstream of MAPK as well as c-Jun N-terminal kinases (JNKs) during regulation of asymmetric odorant receptor expression (Chuang and Bargmann, 2005) . Consistent with these findings, JNK1-3 and the mammalian MAPK kinases Mkk4 and Mkk7 were recently implicated in early events of axon death signaling downstream of Sarm1 , suggesting that axon degenerative signaling may parallel a signaling cascade in C. elegans. A recent study, however, supports a model whereby Mkk4, MKK7, and JNK1-3 signaling may occur upstream of Sarm1 (Walker et al., 2017) . We found that the Drosophila null alleles of each of these genes were not able to suppress pro-degenerative dsarm DARM signaling at 10 dpe, nor were they defective in axon death in our wing assay at 7 dpa ( Table S1B ). Given that Drosophila has a single JNK ortholog (Bsk), our data argue strongly against a requirement for JNK signaling in axon death in vivo. We next explored the possibility that Axed might function downstream of dSarm. We expressed dsarm DARM in clones of axed 2094 , as well as in BSC411 uncovering the axed genomic locus, and scored cell body and axon survival at 10 dpe. Impressively, loss of Axed function completely suppressed dsarm DARM -mediated cell body and axonal degeneration (Figure 4C) . Axed null mutants fully suppressed the effects of dsarm DARM , which is much stronger than the partial protection afforded by Wld S (above). We also found morphologically preserved neurons at 14, 21, and 50 dpe ( Figure 4D ). Loss of Highwire, which is essential for axon death and is thought to act upstream of Nmnat, failed to attenuate dsarm DARM -induced neurodegeneration at 10 dpe ( Figure 4C) . Mutants of the CRL complex and the MAPK signaling pathway also failed to suppress dsarm DARM pro-degenerative activity (Table S2A) . Taken together, our data support the notion that the MAPK cascade is not involved in dSarm-mediated axon death signaling in vivo and that Highwire likely acts upstream or in parallel to dSarm. In contrast, we find that Axed is an essential signaling molecule required downstream of dSarm for execution of pro-degenerative events.
Axed Localizes to Neurites and Synapses
We sought to define the subcellular localization of Axed in neurons. While attempts to generate Axed antibodies failed, we generated a functional version of an endogenously tagged Axed protein (Axed eGFP::FLAG ) by recombination-mediated cassette exchange (RMCE) (Venken et al., 2011 ) ( Figure 5A ). Western blots revealed two different Axed eGFP::FLAG proteins in heads of axed eGFP::FLAG flies ( Figure 5B ), which correspond to the Axed long and Axed short isoforms. We stained larval abdominal nerves with a-HRP to visualize neuronal membranes and found that Axed localized to axons throughout the larval peripheral nerves ( Figure 5C ). In the CNS, Axed was highly enriched in the synaptic neuropil of the larval ventral nerve cord ( Figure 5D , top) and adult brain ( Figure 5E ). The neuropil consists primarily of neuronal axons and dendrites, synapses, and astrocytic processes, while the cortex houses neuronal cell bodies and cortex glia (reviewed in Coutinho-Budd and Freeman, 2013) . We found that Axed is in close proximity or coincident with a marker for presynaptic active zones (nc82) and throughout the neuropil ( Figure 5D ). Axed localization did not overlap with a marker of astrocytic processes (a-GAT) ( Figure 5D ). These data indicate that Axed is expressed in neurons and enriched in neuronal processes.
To explore the possibility whether Axed localization changes after injury, we performed unilateral antennal ablation and visualized Axed eGFP::FLAG intensity over time in antennal lobes ( Figures  5E and 5F ). Axed eGFP::FLAG signals remained unchanged for 2 hr after injury, followed by a small, but significant increase at 4 and 6 hr after injury, which returned to baseline by 24 hr after injury. These data are consistent with the notion that Axed eGFP::FLAG localization or levels transiently change in response to axonal injury.
Depletion of Nmnat Activates Axon Degeneration through Axed
The NAD + biosynthetic enzyme Nmnat is required for axon survival. One isoform in mammals (Nmnat2) and the sole Drosophila homolog Nmnat (Zhai et al., 2006) function as a labile axon survival factor whose depletion induces Wallerian-like degeneration of even uninjured axons (Fang et al., 2012; Gilley and Coleman, 2010 (Gilley et al., 2015) . Nmnat2 À/À animals likely survive due to the NAD + biosynthetic activity of two additional mammalian Nmnat isoforms, Nmnat1 and Nmnat3 (Gilley and Coleman, 2010) . To explore the relationship between Nmnat, dSarm, and Axed, we used RNA interference to partially knock down Drosophila Nmnat (nmnat RNAi ). In the wing, nmnat RNAi clones underwent complete axon and cell body degeneration within 8-10 dpe ( Figure 6A ), consistent with previous reports (Fang et al., 2012) . Interestingly, nmnat RNAi -mediated degeneration of cell bodies and axons was completely suppressed in axed mutant clones at 10 dpe. This suppression was less robust in dsarm mutants, as a significant fraction of axons and cell bodies underwent degeneration ( Figure 6B) , respectively [Zhai et al., 2006] ). We found that nmnat clones underwent rapid neurodegeneration within 1-2 dpe ( Figure 6C ). At 5 dpe, nmnat single mutants and nmnat, dsarm double mutants both underwent complete neurodegeneration ( Figure 6D ), indicating that dsarm is not required for neurodegeneration induced by Nmnat depletion. In contrast, we found that axed, nmnat double null clones exhibited remarkable (100%) preservation of axons, cell bodies, and dendrites 5 dpe ( Figure 6D) . axed, dsarm, nmnat triple null clones also showed no signs of neurodegeneration, further supporting the notion that Axed is epistatic to dSarm. We observed lasting morphological neuroprotection in axed, nmnat double mutant clones to 30 days, arguing against a short delay of death or transient protective effect ( Figure 6E ) and suggesting that axed mutants are capable of fully suppressing neurodegeneration induced by Nmnat depletion.
Axon Death Pathways Converge on Axed
Our data indicate axed is required for dSarm DARM pro-degenerative signaling and for neurodegeneration induced by Nmnat depletion. We next investigated whether the additional stressor of axotomy would be sufficient to drive the degeneration of axons lacking nmnat, expressing dsarm DARM , or both ( Figure 7 ). Remarkably, when we axotomized 5-day-old axed, nmnat double null clones, we found 100% of all severed axons remained morphologically preserved at 7 dpa. Moreover, we found that expressing dsarm DARM in axed, nmnat double clones was also not sufficient to drive degeneration even when these axons were severed ( Figure 7) . Thus, direct activation of dSarm signaling, loss of Nmnat, and axotomy combined are not sufficient to drive the destruction of neurons lacking Axed. These findings indicate that all known axon death signaling pathways converge on axed to promote the disassembly of severed axons.
Severed Axon Death Defective Axons Remain Functionally Preserved for Weeks
Axon death signaling pathway mutants exhibit robust suppression of morphological degeneration after axotomy. Wld S axons remain capable of propagating action potentials and stimulating evoked release at NMJs (Mack et al., 2001) , and in Drosophila larvae, hiw mutants have also been show to preserve evoked and spontaneous neurotransmitter release at NMJs 24 hr after injury in an ex vivo filet preparation (Xiong et al., 2012) . However, it remains unclear whether severed axons that fail to undergo axon death (i.e., dsarm, hiw, axed mutants) remain functionally preserved over the time span of weeks after injury, can respond (D) Axed is predominantly expressed in neurites and synapses in larval neuropil. Top: Axed eGFP::FLAG and merge with HRP staining. Scale bar, 10 mm. Below: Axed is found in close proximity to synapses (nc82 staining, top) and to a lesser extent to astrocytes (bottom). Scale bar, 5 mm.
(E) Axed is upregulated upon axon injury in adult brains. Bilateral antennal ablation was performed, and the antennal lobe in brains analyzed before and 2, 4, 6, and 24 hr after antennal ablation. Blue, nc82 staining. Scale bar, 10 mm.
(F) Quantification of Axed levels pre-and post-injury. Ordinary one-way ANOVA with multiple comparisons test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
to multiple evoked stimulations in vivo, or are capable of eliciting complex behavioral output in the CNS when stimulated. We used optogenetics combined with a behavioral readout to assay the ability of severed axons in control and axon death mutants to drive a complex grooming behavior in adult Drosophila. Stimulation of mechanosensory chordotonal neurons that make up the Johnston's organ (JO) in the adult antennae is sufficient to elicit antennal grooming (Hampel et al., 2015; Seeds et al., 2014) . We drove expression of CsChrimson (a red shifted channelrhodopsin) specifically in these neurons, fed animals all-trans retinal, and subjected them to a brief red light stimulus to activate these neurons (Figure 8) . The dynamics of grooming responses were examined in multiple individual flies before injury (control) and upon antennal ablation at 30 min (30 mpa, i.e., before axons degenerate) and 3 days post-antennal ablation (3 dpa, i.e., after axons have degenerated) ( Figure 8A ; Movie S1). Upon red light activation, antennal grooming was observed at similar levels in uninjured controls and 30 mpa ( Figures 8B and 8C ), indicating that stimulation of even the distal severed axons of JO neurons is sufficient to elicit grooming behavior. However, at 3 dpa, after axons had degenerated ( Figure S7A ), grooming was eliminated. We next generated MARCM clones with either wild-type or axon death mutants, severed JO axons, and then scored for both morphological preservation of JO axons and synapses (Figure S7A) and their ability to elicit grooming. Individual flies were tested before and after antennal ablation at 3, 7, and 15 dpa. Animals containing wild-type JO MARCM clones lost the ability to groom upon red light activation at 3 dpa, whereas flies containing axon death mutant JO MARCM clones were still able to elicit grooming (Movie S2; Figures 8D and S7B-S7F ). Flies containing axon death mutant clones responded to red light stimulation with grooming for more than 2 weeks, albeit with somewhat different kinetics ( Figures 8D and S7B -S7F for individual ethograms). These data argue that axon death mutants axed, dsarm, and hiw preserve axons in a functionally competent state for weeks after injury in vivo and that axons exhibiting this long-term survival remain integrated in complex circuits.
DISCUSSION
Axed Is a Novel Axon Death Signaling Molecule
Here we present the identification and initial characterization of the BTB and BACK domain molecule Axed. Loss of Axed function was sufficient to block axon death for the lifespan of the fly, and axed mutants were neuroprotective in all neurons tested. Axed, like dSarm, appears to function selectively in axon death during WD, as axed mutants blocked neither cell death nor developmental pruning of axons or dendrites, supporting the notion that the Nmnat-depletion/dSarm/Axed signaling pathway is engaged specifically in response to axonal injury. However, it remains possible that while Axed or dSarm elimination is not sufficient to block cell death, redundant genetic pathways might work together with dSarm and Axed in the context of apoptotic cell death.
Axed encodes a previously uncharacterized BTB and BACK domain protein. The best-characterized role for BTB-containing proteins is the recruitment of substrates to CRL complexes for ubiquitin tagging and proteasome degradation, where BTB domains function in homo-or hetero-dimerization while the BACK domain (often with the BTB domain) interacts directly with Cullins (Stogios and Privé , 2004) . Typically, the C-terminal regions in BTB domains molecules function within CRL complexes to bind target substrates designated either for ubiquitination by the CRL and subsequent degradation by the proteasome or for signaling. The BTB and BACK domains of Axed are required for optimal Axed function in vivo based on their partial abilities to rescue axon death phenotypes in axed mutant backgrounds. In contrast, the C terminus appears to be absolutely essential for Axed function as Axed DCterm completely fails to rescue axon death. This is not likely due to destabilization of the molecule lacking the C terminus, since Axed DCterm can be stably expressed in Drosophila S2 cells. Despite extensive attempts to implicate the wide array of CRLs in Drosophila in axon death and Axed function, we found no evidence supporting a role for CRLs in axon degeneration. Given that there are five Cullin-like molecules in the Drosophila genome, it seems possible that genetic redundancy between Cullins might explain the lack of phenotype. Alternatively, Axed could be functioning to promote axon death in a completely novel Cullin-independent manner.
Future studies aimed at identifying direct binding partners for Axed will be essential to resolve these issues. If Axed functions as a bridging molecule for CRL ubiquitination activity, of particular interest will be identifying molecules that bind to the Axed C-terminal putative substrate binding domain. Sarm1 functions in axons after injury (Gerdts et al., 2015) . Given that Axed functions genetically downstream of Sarm1, we propose that Axed also functions in axons. Using a functional, endogenously enhanced GFP-tagged version of Axed (Axed eGFP ), we found that Axed protein is enriched in the neuropil in both the larva and the adult nervous system. The Drosophila larval neuropil is highly enriched for dendrites and axons and is the site of all CNS synapse formation. Axed eGFP signals overlapped extensively with axons, dendrites, and synapses, further supporting a cell-autonomous role for Axed in neurons during axon death. Axed eGFP is also present in the adult neuropil, and Axed Functions Downstream of dSarm axed mutant phenotypes are indistinguishable from dsarm mutants with respect to axon preservation after injury. In addition, axed mutants completely blocked the pro-degenerative activity of the gain-of-function dSarm molecule dSarm DARM in vivo.
These genetic data strongly support a model whereby Axed functions genetically downstream of dSarm, and argue that dSarm and Axed drive axon death through the same genetic pathway. dSarm DARM appears to induce a Wallerian-like program in vivo based on several observations. First, the explosive fragmentation we observe is morphologically similar to WD. Second, dSarm DARM -induced degeneration can be suppressed partially by Wld S , whose activity is highly selective to WD (Simonin et al., 2007; Wang et al., 2006) . Third, dSarm DARM pro-degenerative activity can be fully suppressed in axed mutants. Finally, all structural and biochemical studies to date support the notion that elimination of the N-terminal ARM domain of dSarm (Drosophila), TIR-1(C. elegans), or Sarm1 (mammals) leads to the production of a gain-of-function molecule that activates signaling (Chuang and Bargmann, 2005; Gerdts et al., 2013; Yang et al., 2015) . That dSarm DARM signaling in the absence of injury is potently suppressed by axed mutants provides a compelling argument for Axed to act downstream of dSarm. The nature of the genetic program that drives death of neuronal cell bodies after dSarm/Sarm1 activation remains mysterious. We were unable to block it with the broad caspase inhibitor P35. Related studies in mouse found a lack of evidence for apoptotic signaling molecules, necroptosis, and parthanatos in death induced by activated Sarm1 (Summers et al., 2014) . The Examples of axon clones of different genotypes that were aged for 5 days (5 dpe), injured, and analyzed 7 days later (7 dpa). Scale bar, 5 mm. The number of intact neurons is indicated in the upper right corner in each example. Below: percent of axons that are intact or preserved (before or after injury, respectively). nd, not determined (axons in these genotypes are gone by 5 dpe even without injury).
observation that we were able to induce robust degeneration of axons, dendrites, and cell bodies by adult-specific induction of dSarm DARM in adult PDF + neurons, even in the absence of injury, suggests that dSarm DARM could provide a useful tool for conditional removal of selected neurons from adult circuits for functional studies.
In the larger context of axon death signaling, our finding that mutations in hiw do not suppress dSarm DARM in vivo agrees with the proposed model that Hiw/Phr1 acts genetically upstream of dSarm/Sarm1 and Nmnat degradation (Babetto et al., 2013; Xiong et al., 2012) . The position of the MAPK signaling cascade relative to dSarm/Sarm1 is still debated in the field and remains to be determined (Walker et al., 2017; Yang et al., 2015) . The fact that the Drosophila genome houses only a single JNK family member, and our observation that null alleles had no axon death phenotype, argues strongly against a central role for JNK signaling in axon death. With respect to their roles in the functional disassembly of axons, we have demonstrated that blocking axon death with mutations in dsarm, axed, or highwire is sufficient to preserve axons in a functional state in neural circuits where they can elicit complex grooming behaviors for weeks after axotomy. Therefore, axon death mutants, like the Wld S molecule ( activity then drives pathological depletion of axonal NAD + pools, causing catastrophic energy failure that ultimately drives axon degeneration. We made a number of observations that are difficult to rectify with a simple Nmnat2/Sarm1-dependent NAD + depletion model. The first is that expression of dSarm DARM , which based on previous reports should rapidly degrade axonal NAD + and normally leads to rapid axonal degeneration (Essuman et al., 2017) , can be completely suppressed by loss of Axed. If the terminal step in axonal death were Nmnat2/Sarm1-dependent depletion of NAD + pools, it is hard to imagine how the NAD + hydrolase activity of the Sarm1 TIR domain, once unleashed, could be suppressed by the loss of a BTB and BACK domain protein (i.e., Axed). We favor the alternative hypothesis that Sarm1 signaling, perhaps through its TIR domain NAD + hydrolase activity, activates an Axed-dependent downstream signaling pathway essential for axon death. ADP-ribosylation of targets is one mechanism that allows certain E3 ubiquitin ligases to bind substrates (Kalisch et al., 2012; Li et al., 2015) . There is certainly a tight association between NAD + metabolism and axon death signaling, and the NAD + hydrolase activity associated with the Sarm1 TIR domain can lead to the production of ADPr (Essuman et al., 2017) . Perhaps BTB and BACK domain proteins like Axed also require ADP-ribosylation of selected targets during axon death. In this model, the degradation of NAD + would be a byproduct of the reaction, not a driving force. Nmnat2 À/À mutant mice die perinatally with neurons containing short axons, but these embryos can be rescued to adulthood by Sarm1 À/À null mutations (Gilley et al., 2015) . It is likely that 
levels in axons in
Drosophila will be essential to answer this question, but current NAD + sensors (Cambronne et al., 2016) have not yet provided sufficient sensitivity in our hands.
Axed appears to sit genetically at a convergence point in axon death signaling. There are three ways to activate axon death: axotomy, Nmnat/Nmnat2 depletion, or expression of gain-of-function dSarm/Sarm1. Axed mutants, but not dsarm, can suppress each of these treatments, and, amazingly, axed mutants can even survive the combination of all three insults at once. The neuroprotective effects of axed therefore exceed those of dsarm mutants. It remains to be determined whether any of the four putative mammalian paralogs (BTBD1, BTBD2, BTBD3, and BTBD6) ( Figure S8 ) play a role in axon death, but this seems likely based on the strong conservation of dSarm/Sarm1 function in axon degeneration. If so, these would represent important new therapeutic targets for blocking axon death in neurological diseases such as traumatic brain injury, peripheral neuropathy, or nerve injury, where dSarm/Sarm1 signaling is known to drive axon loss (Geisler et al., 2016; Henninger et al., 2016; Osterloh et al., 2012) .
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Immunohistochemistry Unpruned a/b MB neurons: Anti-FasII AB staining was performed as described in : at corresponding time points, pupal brains were fixed in 4% formaldehyde in PTX for 20 min at RT, and washed five times 2 min with PTX. Brain dissection was performed in PTX, and dissected brain were fixed in 4% formaldehyde in PTX for 10 min at RT, which was followed by five 2 min washes with PTX. The following ABs were used: 1:5 Mouse anti-FasII (DSHB) at 4 C overnight, and 1:200 Cy3 Rabbit anti-Mouse at RT for 3h (Jackson lab). Brains were then washed in PTX three times 10 min at RT, and mounted in Vectashield for microscopy.
Pigment dispersing factor (PDF + ) neurons: Anti-PDF AB staining was performed as described in (Muthukumar et al., 2014) : decapitated heads were fixed in 4% formaldehyde in PTX for 20 min at RT, and washed five times 2 min with PTX. Brain dissection was performed in PTX, and dissected brain were fixed in 4% formaldehyde in PTX for 10 min at RT, which was followed by five 2 min washes with PTX. The following ABs were used: 1:10 Mouse anti-PDF (DSHB) at 4 C overnight, and 1:200 FITC Donkey anti-Mouse 2h at RT (Jackson lab). Brains were then washed in PTX three times 10 min at RT, and mounted in Vectashield for microscopy.
Dorsal dendrite arborization (dda) sensory neurons: Anti-HRP (Horseradish Peroxidase) AB staining was performed as described in (Wong et al., 2013) : larval fillets were prepared in PBS and fixed in 4% formaldehyde in PBS for 15 min. Fillets were washed in 1% Triton X-100 in PBS three times 10 min each, and incubated with the following AB: 1:200 Cy5 Goat anti-HRP (Jackson lab) at 4 C overnight. Fillets were then washed in PTX three times 10 min at RT and mounted in Vectashield for microscopy.
Heat shock treatment MARCM double clone crosses were passed every day, and 1h heat shock application at 37 C performed at 5 days post-initial cross set up (Neukomm et al., 2014) .
Optogenetic activation of grooming behavior MARCM crosses were performed on rich semi-defined medium (Backhaus et al., 1984) containing 200 mM all-trans retinoic acid (Hampel et al., 2015) : CsChrimson experiments were performed in the dark, and flies were visualized for recording using an 850-nm infrared light source at 2 mW/cm2 intensity (Mightex, Toronto, CA), which flies cannot see. For CsChrimson activation, 656-nm red light at 27 mW/cm2 intensity (Mightex) was used. Red light stimulus parameters were delivered using a NIDAQ board controlled through Labview (National Instruments, Austin, TX). Red light frequency was 10 Hz for 10 s, followed by 30 s interstimulus intervals (total of 3 stimulations). Flies were recorded, and videos were manually analyzed using VLC player (www.videolan.org). Grooming activity (ethogram) was plotted as bins: 1 bin was defined as grooming event(s) per second. Ethograms were visualized using R (www.r-project.org). The ablation of 2 nd antennal segments did not damage the rest of the head or lead to mortality of the animals. Flies that died during the analysis window (3 days post-ablation -15 days post-ablation) were excluded.
Replication
For all experiments (lethality complementation, wing injury & antennal ablation, grooming, western blots) at least 3 biological replications were performed for each genotype and/or condition.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data acquisition and quantification were performed non-blinded. Acquisition was performed in Microsoft Excel, statistical analyses were performed using GraphPad Prism 7. Statistical details (definition of test, exact value of n (e.g., number of wings, number of brains, etc.), mean ± deviations, p values) are listed in Figure Legends and below. All statistical comparisons were conducted on data originating from 3 or more biologically independent experimental replicates. Figure 4C : 2-way ANOVA with Sidak's multiple comparisons test, n = 20 wings, mean ± SEM, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. Figure 5F : Ordinary 1-way ANOVA with Tukey's multiple comparisons test, n R 6 brains, mean ± SEM, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. Figure 6B : 2-way ANOVA with Sidak's multiple comparisons test, n = 20 wings, mean ± SEM, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. Figure 8C : Ordinary 1-way ANOVA with Tukey's multiple comparisons test, n = 11 male flies, mean ± SD, ns = not significant, **** = p < 0.0001. Figure 8D : 2-way ANOVA with Tukey's multiple comparisons test, n R 12 flies, mean ± SD, **** = p < 0.0001. Figure S7B -F: 2-way ANOVA with Tukey's multiple comparisons test, n R 12 flies, mean ± SD, **** = p < 0.0001. Figure S7 and Figure 8 : Wild-type grooming scores were compared before with after antennal ablation (B, chromosome 3L; E, X chromosome, respectively). At each time point, mutant grooming scores were compared with corresponding wild-type grooming scores.
